期刊文献+

以新视角观察p53家族在肺癌发生及治疗中的独特作用 被引量:5

P53 Family Proteins Provide New Insights into Lung Carcinogenesis and Clinical Treatment
下载PDF
导出
摘要 P53作为转录因子,其转录激活功能维持了基因组的稳定性,对防止肿瘤的形成起着重要作用,是目前研究得最为广泛、深入的抑癌基因,被称为"基因卫士"。P53家族的成员p63、p73与p53在DNA结合结构域上有高度的同源性,某些p53家族亚型可以与p53-反应基因相结合起着转录激活的作用,另外一些则起着负性调节作用。肺癌是世界上患病率最高的恶性肿瘤之一,p53家族成员在肺癌中的异常表达与肺癌的发生有密切联系,并导致不良的预后及对放疗、化疗的抵抗。对p53家族成员在肺癌致病机制的深入研究可有助于为临床提供合理的化疗方案及靶向治疗策略。本文着重回顾总结p53家族成员在肺癌发生、化疗敏感性以及肺癌靶向治疗中的独特的作用。 The transcription activation of p53 plays an important role in the maintenance of genetic stability. P53 is an intensive study tumor suppressor, which has been called the "gene guider". The p53 family members p63, p73 have high homologous sequence with p53. Some of them can bind to the p53-responsive genes and transcript the downstream genes. Human lung cancer is one of the most common malignant tumors in the world. Abnormality of the p53 gene is the significant event in lung cancers, which leads to the poor prognosis and the resistance of chemotherapy. A deep understanding of the rela- tionship between p53 family members and lung cancers can provide a more reasonably targeted clinical approach. This paper will focus on the special function of pS3 family members in the development, chemosensitivity and target treatment of lung cancer,
出处 《中国肺癌杂志》 CAS 北大核心 2013年第8期422-426,共5页 Chinese Journal of Lung Cancer
关键词 P53 P63 P73 肺肿瘤 化疗敏感性 靶向治疗 P53/p63/p73 Lung neoplasms Chemose nsitivity Target treatment
  • 相关文献

参考文献7

二级参考文献64

  • 1王中华,缪小平,谭文,张湘茹,徐兵河,林东昕.XRCC1单核苷酸多态与晚期非小细胞肺癌对铂类药物化疗敏感性的相关性[J].癌症,2004,23(8):865-868. 被引量:56
  • 2Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol,2000,31(4) : 406-414. Erratum in: Hum Pathol, 2000 , 31(6)
  • 3Wu M, Wang B, Gil J, et al. p63 and TTF1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol,2003,119(5): 696-702.
  • 4Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.Nature,1999,398(6729) : 714-718.
  • 5Yang A,Kaghad M,Wang Y,et al.p63,a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell,1998,2(3): 305-316.
  • 6Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest, 2000,80 (12) :1943-1949.
  • 7Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium,pulmonary squamous neoplasms, and other pulmonary tumors.Hum Pathol,2002,33(9): 921-926.
  • 8Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium,pulmonary squamous neoplasms, and other pulmonary tumors.Hum Pathol,2002,33(9): 921-926.
  • 9Travis WD, Colby TV, Corrin B, et al. WHO histological typing of lung and pleural tumors. 3rd ed. Geneva: WHO,1999.
  • 10Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumors. 5th ed. New York: Wiley-Liss, Inc,1997.

共引文献76

同被引文献40

  • 1黄枫,申洪.基于Intel RNG的真随机数生成器研究[J].第一军医大学学报,2004,24(9):1091-1095. 被引量:9
  • 2张丽华,侯振江.p53基因在肺癌研究中的进展[J].临床肺科杂志,2006,11(1):59-60. 被引量:18
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Ciin, 2013, 63(1): 11-30.
  • 4Molina J, Yang P, Cassivi S et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 2008, 83(5): 584-594.
  • 5Mulshine J, Sullivan D. Clinical practice. Lung cancer screening. N Engl J Med, 2005, 352(26): 2714-2720.
  • 6Prager GW, Poettler M, Unseld M, et al. Angiogenesis in cancer: anti- VEGF escape mechanisms. Transl Lung Cancer Res, 2011, i (1): 14-25.
  • 7Gu X, Ma C, Yuan D, et al. Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review. Transl Lung Cancer Res, 2011, 1(1): 36-44.
  • 8Yang L, Li Y, Ling X, et al. A common genetic variant (97906C>A) ofDAB21P/AIPI is associated with an increased risk and early onset of lung cancer in Chinese males. PLoS One, 2011j 6(I0): e26944.
  • 9Yoo N Park S, Lee S. Mutational analysis oftumour suppressor gene NF2 in common solid cancers and acute leukaemias. Pathology, 2012 441: 29-32.
  • 10Ma C, Wei S, Song Y. T790M and acquired resistance ofEGFR TKI: a literature review of clinical reports. J "Ihorac Dis, 2011, 3(1): 10-18.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部